loadpatents
name:-0.033582925796509
name:-0.019644021987915
name:-0.01791787147522
Gunde; Tea Patent Filings

Gunde; Tea

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gunde; Tea.The latest application filed is for "multispecific antibodies having specificity for tnfa and il-17a, antibodies targeting il-17a, and methods of use thereof".

Company Profile
16.16.30
  • Gunde; Tea - Zurich CH
  • GUNDE; Tea - Zuerich CH
  • GUNDE; Tea - Waedenswil CH
  • Gunde; Tea - Dubendorf CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-HSA antibodies
Grant 11,365,240 - Gunde , et al. June 21, 2
2022-06-21
Anti-CD3 antibodies
Grant 11,319,371 - Gunde , et al. May 3, 2
2022-05-03
Multispecific Antibodies Having Specificity For Tnfa And Il-17a, Antibodies Targeting Il-17a, And Methods Of Use Thereof
App 20220127350 - Urech; David ;   et al.
2022-04-28
Antibodies Targeting Cd137 And Methods Of Use Thereof
App 20210395379 - Gunde; Tea ;   et al.
2021-12-23
Anti-tnf-alpha-antibodies And Functional Fragments Thereof
App 20210198353 - GUNDE; Tea ;   et al.
2021-07-01
Anti-TNF-.alpha.-antibodies and functional fragments thereof
Grant 10,975,143 - Gunde , et al. April 13, 2
2021-04-13
Antibodies Targeting Cd137 And Methods Of Use Thereof
App 20200332015 - GUNDE; Tea ;   et al.
2020-10-22
Novel Anti-hsa Antibodies
App 20200325214 - GUNDE; Tea ;   et al.
2020-10-15
Anti-TNF.alpha.-antibodies and functional fragments thereof
Grant 10,787,508 - Gunde , et al. September 29, 2
2020-09-29
Anti-tnf-alpha-antibodies And Functional Fragments Thereof
App 20200299375 - GUNDE; Tea ;   et al.
2020-09-24
Anti-TNF.alpha.-antibodies and functional fragments thereof
Grant 10,774,140 - Gunde , et al. Sept
2020-09-15
Antibodies Targeting Pdl1 And Methods Of Use Thereof
App 20200283528 - GUNDE; Tea ;   et al.
2020-09-10
Anti-TNF-alpha-antibodies and functional fragments thereof
Grant 10,759,852 - Gunde , et al. Sep
2020-09-01
Hetero-dimeric Multi-specific Antibody Format Targeting At Least Cd3 And Hsa
App 20200181263 - Urech; David ;   et al.
2020-06-11
Stable And Soluble Antibodies Inhibiting Vegf
App 20200172608 - Borras; Leonardo Jose ;   et al.
2020-06-04
Novel Anti-cd3 Antibodies
App 20200115449 - GUNDE; Tea ;   et al.
2020-04-16
Stable and soluble antibodies inhibiting VEGF
Grant 10,590,193 - Borras , et al.
2020-03-17
Anti-tnf-alpha-antibodies And Functional Fragments Thereof
App 20190194310 - GUNDE; Tea ;   et al.
2019-06-27
Anti-tnf-alpha-antibodies And Functional Fragments Thereof
App 20190153089 - GUNDE; Tea ;   et al.
2019-05-23
Anti-TNFalpha-Antibodies and Functional Fragments Thereof
App 20190092850 - Gunde; Tea ;   et al.
2019-03-28
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20180371074 - Borras; Leonardo ;   et al.
2018-12-27
Stable and soluble antibodies inhibiting TNF alpha
Grant 10,100,111 - Borras , et al. October 16, 2
2018-10-16
Bispecific Constructs and Their Use in the Treatment of Various Diseases
App 20180282419 - Urech; David ;   et al.
2018-10-04
CD3 and IL-23 receptor binding bispecific constructs and their use in the treatment of various diseases
Grant 10,077,312 - Urech , et al. September 18, 2
2018-09-18
Stable And Soluble Antibodies Inhibiting Vegf
App 20180072802 - Borras; Leonardo ;   et al.
2018-03-15
Stable and soluble antibodies inhibiting VEGF
Grant 9,873,737 - Borras , et al. January 23, 2
2018-01-23
Novel Multispecific Molecules And Novel Treatment Methods Based On Such Multispecific Molecules
App 20170073415 - URECH; David ;   et al.
2017-03-16
Bispecific Constructs And Their Use In The Treatment Of Various Diseases
App 20160368987 - URECH; David ;   et al.
2016-12-22
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20160251428 - Borras; Leonardo ;   et al.
2016-09-01
Stable and soluble antibodies inhibiting TNF alpha
Grant 9,422,366 - Borras , et al. August 23, 2
2016-08-23
Novel Antibodies
App 20160090416 - GUNDE; Tea ;   et al.
2016-03-31
Bispecific Constructs And Their Use In The Treatment Of Various Diseases
App 20160083473 - URECH; David ;   et al.
2016-03-24
Depletion Of Il23r Expressing Cells In The Treatment Of Various Diseases
App 20150329637 - URECH; David ;   et al.
2015-11-19
Stable And Soluble Antibodies Inhibiting Vegf
App 20150274820 - Borras; Leonardo ;   et al.
2015-10-01
Stable and soluble antibodies inhibiting VEGF
Grant 9,090,684 - Borras , et al. July 28, 2
2015-07-28
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20140193400 - Borras; Leonardo ;   et al.
2014-07-10
Stable and soluble antibodies inhibiting TNF.alpha.
Grant 8,673,310 - Borras , et al. March 18, 2
2014-03-18
Stable And Soluble Antibodies Inhibiting Vegf
App 20140004114 - Borras; Leonardo ;   et al.
2014-01-02
Stable and soluble antibodies inhibiting VEGF
Grant 8,349,322 - Borras , et al. January 8, 2
2013-01-08
Stable And Soluble Antibodies Inhibiting Vegf
App 20120014958 - Borras; Leonardo ;   et al.
2012-01-19
Stable And Soluble Antibodies Inhibiting Tnf Alpha
App 20110159007 - Borras; Leonardo ;   et al.
2011-06-30
Method For Decreasing Immunogenicity
App 20110152505 - Urech; David ;   et al.
2011-06-23
Method for the identification and/or validation of receptor tyrosine kinase inhibitors
Grant 7,566,528 - Gunde , et al. July 28, 2
2009-07-28
Protein kinase inhibitors
App 20070149535 - Berset; Catherine ;   et al.
2007-06-28
Method for the identification and/or validation of receptor tyrosine kinase inhibitors
App 20050239049 - Gunde, Tea ;   et al.
2005-10-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed